Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
AIDS (London, England)|December 4, 2004
Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in MontrealJean-Pierre Routy, Nimâ Machouf, Michael D Edwardes, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 12, 2016
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialJeffrey M Jacobson, Jean-Pierre Routy, Seth Welles, et al.The Journal of Antimicrobial Chemotherapy|June 12, 2009
Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistanceJean-Michel Molina, Mounir Ait-Khaled, Roberto Rinaldi, et al.Viral Immunology|April 9, 2010
Changes in function of HIV-specific T-cell responses with increasing time from infectionMichel L Ndongala, Philomena Kamya, Salix Boulet, et al.Medicine|July 15, 2022
Cross-sectional comparison of age- and gender-related comorbidities in people living with HIV in CanadaJason M Brunetta, Jean-Guy Baril, Joseph J de Wet, et al.Medicine|November 21, 2020
Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIVMohamed N'dongo Sangaré, Jean-Guy Baril, Alexandra de Pokomandy, et al.Journal of Virology|April 8, 2011
Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57Philomena Kamya, Salix Boulet, Christos M Tsoukas, et al.The Journal of Infectious Diseases|January 25, 2015
Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV InfectionMohammad-Ali Jenabian, Mohamed El-Far, Kishanda Vyboh, et al.Journal of the International AIDS Society|December 6, 2023
Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey dataCarla M Doyle, Rachael M Milwid, Joseph Cox, et al.Scientific Reports|March 16, 2016
Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressorsMohamed El-Far, Pascale Kouassi, Mohamed Sylla, et al.Pageof 7